What does “GLP-1-friendly” actually mean?

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...